Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mineralocorticoid Receptor Antagonist”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Large-scale testing (Phase 3)Study completedNCT02722265
What this trial is testing

Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo Co., Ltd. 368
Post-approval studies (Phase 4)Study completedNCT03683069
What this trial is testing

Mineralocorticoid Receptor (MR) Antagonist (Eplerenone) vs Amlodipine and STRIATIN

Who this might be right for
HypertensionGenetics Hypertension
Brigham and Women's Hospital 90
Large-scale testing (Phase 3)Study completedNCT02807974
What this trial is testing

Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria

Who this might be right for
Hypertension
Daiichi Sankyo Co., Ltd. 51
Testing effectiveness (Phase 2)Study completedNCT02497300
What this trial is testing

Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease

Who this might be right for
Chronic Kidney DiseaseAlbuminuria
University of Alabama at Birmingham 21
Not applicableLooking for participantsNCT07328230
What this trial is testing

Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism

Who this might be right for
Idiopathic HyperaldosteronismHyperaldosteronism
Chinese Academy of Medical Sciences, Fuwai Hospital 172
Not applicableWithdrawnNCT05806970
What this trial is testing

Email Nudges to Improve GDMT (MRA) Adherence in Heart Failure

Who this might be right for
Heart Failure With Reduced Ejection Fraction
University of California, Los Angeles
Testing effectiveness (Phase 2)Ended earlyNCT04300881
What this trial is testing

Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid Antagonists)

Who this might be right for
Vitreomacular TractionSubretinal Edema
Wagner Macula & Retina Center 2
Post-approval studies (Phase 4)Study completedNCT01837108
What this trial is testing

Eplerenone and Extracellular Adenosine Formation

Who this might be right for
Pharmacodynamics
Radboud University Medical Center 14
Large-scale testing (Phase 3)Ended earlyNCT04968184
What this trial is testing

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Diseases
KBP Biosciences 652
Not applicableStudy completedNCT03174847
What this trial is testing

Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism

Who this might be right for
Primary AldosteronismPrimary Aldosteronism Due to Aldosterone Producing AdenomaPrimary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
Changi General Hospital 57
Testing effectiveness (Phase 2)Study completedNCT02345057
What this trial is testing

Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria

Who this might be right for
Diabetic Nephropathy
Daiichi Sankyo 365
Large-scale testing (Phase 3)Study completedNCT02807987
What this trial is testing

Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment

Who this might be right for
Hypertension With Moderate Renal Impairment
Daiichi Sankyo Co., Ltd. 58
Large-scale testing (Phase 3)Study completedNCT02585843
What this trial is testing

Mineralocorticoid Receptor Antagonists (MRA) in Heart Failure (HF) and Loop Diuretic Resistance

Who this might be right for
Heart Failure
Columbia University 20
Post-approval studies (Phase 4)Study completedNCT03344159
What this trial is testing

Spironolactone Therapy in Chronic Stable Right HF Trial

Who this might be right for
Chronic Right-Sided Heart FailurePulmonary Arterial HypertensionPulmonary Hypertension, Primary, 2+3 more
Ottawa Heart Institute Research Corporation 15
Not applicableStudy completedNCT01728493
What this trial is testing

Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment

Who this might be right for
Primary AldosteronismPrimary Hyperaldosteronism
Radboud University Medical Center 700
Post-approval studies (Phase 4)UnknownNCT05814770
What this trial is testing

Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism

Who this might be right for
Primary AldosteronismHypertension
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 96
Not applicableStudy completedNCT03789357
What this trial is testing

Prevalence of Primary Aldosteronism in Patients With Stroke

Who this might be right for
Primary AldosteronismStroke
Changi General Hospital 300
Post-approval studies (Phase 4)Study completedNCT06094920
What this trial is testing

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

Who this might be right for
Diabetes Mellitus Type 2 With ProteinuriaDiabetes Mellitus, Type 2Diabetes Mellitus+10 more
University Medical Center Groningen 12
Not applicableUnknownNCT05873400
What this trial is testing

Effect of Renin Angiotensin Aldosterone System Genetic Polymorphism on the Pharmacological Effect of Mineralocorticoid Receptor Antagonists in Patients With Myocardial Infarction

Who this might be right for
Myocardial Infarction
Ain Shams University 102
Not applicableLooking for participantsNCT06108427
What this trial is testing

REnin-guided TherApy With MinEralocorticoid Receptor Antagonists in Primary Aldosteronism - Feasibility Study

Who this might be right for
Primary Aldosteronism
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 58
Load More Results